949 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Will UPS (UPS) Beat Estimates Again in Its Next Earnings Report? https://www.zacks.com/stock/news/2211642/will-ups-ups-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2211642 Jan 17, 2024 - UPS (UPS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
U.S. Bancorp's (USB) Q4 Earnings Meet Estimates, Costs Up https://www.zacks.com/stock/news/2211682/u-s-bancorp-s-usb-q4-earnings-meet-estimates-costs-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2211682 Jan 17, 2024 - U.S. Bancorp's (USB) Q4 earnings gain from a rise in revenues and an improvement in credit quality. However, higher expenses and lower NII act as headwinds.
Ulta Beauty (ULTA) Up on Omni-channel Strength & Skincare Sales https://www.zacks.com/stock/news/2211589/ulta-beauty-ulta-up-on-omni-channel-strength-skincare-sales?cid=CS-ZC-FT-analyst_blog|rank_focused-2211589 Jan 17, 2024 - Ulta Beauty (ULTA) continues to invest in enhancing guest experience in all touch points. A positive view of the beauty space is keeping the company well-positioned.
CSX Gears Up to Report Q4 Earnings: What's in the Cards? https://www.zacks.com/stock/news/2211671/csx-gears-up-to-report-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2211671 Jan 17, 2024 - CSX's fourth-quarter 2023 revenues are expected to have been weighed down by segmental weakness.
Cboe Global (CBOE) Up 53% in a Year: Time to Add to Portfolio? https://www.zacks.com/stock/news/2212369/cboe-global-cboe-up-53-in-a-year-time-to-add-to-portfolio?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2212369 Jan 18, 2024 - Cboe Global's (CBOE) strong market position, global reach, proprietary products' strength and solid capital position poise it well for growth.
3M (MMM) Gears Up to Post Q4 Earnings: Is a Beat in Store? https://www.zacks.com/stock/news/2212826/3m-mmm-gears-up-to-post-q4-earnings-is-a-beat-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2212826 Jan 19, 2024 - 3M's (MMM) fourth-quarter 2023 results are likely to have gained from strength across its automotive OEM and medical solutions businesses. However, weak commercial solutions and transportation safety markets might have hurt its results.
Mesoblast (MESO) Up on Rare Pediatric Disease Tag for Heart Drug https://www.zacks.com/stock/news/2212927/mesoblast-meso-up-on-rare-pediatric-disease-tag-for-heart-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2212927 Jan 19, 2024 - Mesoblast's (MESO) Revascor (rexlemestrocel-L) gets FDA's Rare Pediatric Disease designation for treating children with congenital heart disease. Shares rise in after-hours trading.
Dave & Buster's (PLAY) Up 36% in Three Months: More Upside Left? https://www.zacks.com/stock/news/2213012/dave-buster-s-play-up-36-in-three-months-more-upside-left?cid=CS-ZC-FT-analyst_blog|rank_focused-2213012 Jan 19, 2024 - Dave & Buster's (PLAY) focuses on introducing more entertainment options, enhancing guest engagement and implementing a digital guest platform to drive growth.
Xerox (XRX) Gears Up for Q4 Earnings: What's in the Cards? https://www.zacks.com/stock/news/2213586/xerox-xrx-gears-up-for-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213586 Jan 22, 2024 - Xerox's (XRX) fourth-quarter 2023 earnings and revenues are likely to decrease year over year.
Pangaea Logistics (PANL) Is Up 8.92% in One Week: What You Should Know https://www.zacks.com/stock/news/2213655/pangaea-logistics-panl-is-up-8-92-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2213655 Jan 22, 2024 - Does Pangaea Logistics (PANL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Pages: 1...7172737475767778798081...95

<<<Page 76>